Related Tags >> FDA Andrx Generics Prostate Cancer

Watson Pharmaceuticals News

Most Popular Watson Pharmaceuticals Story

ALSO NOTED: Advanced Magnetics touts Phase III data; MicroIslet makes staffing changes; and much more...

July 23, 2007 — 6:59am ET

> Advanced Magnetics has announced preliminary positive results from its fourth and final planned Phase III clinical trial of ferumoxytol as an intravenous iron replacement therapeutic in chronic... Read more...

Watson Pharmaceuticals Press Releases

Debiopharm Announces U.S. NDA Filing of Trelstar(R) 6-Month Formulation for Locally Advanced or Metastatic Prostate Cancer
Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA
Watson Pharmaceuticals Receives US FDA Approval for RAPAFLO (silodosin) for the Treatment of Benign Prostatic Hyperplasia
PRESS RELEASE: Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia Fe

Latest Headlines

Watson wins regulatory OK for Rapaflo
October 9, 2008
C&L: Una Ryan leaves Avant
May 14, 2008
ALSO NOTED: Lentigen moves to Gaithersburg; Acorda prices shares; Cytheris releases data; and much more...
February 13, 2008
ALSO NOTED: Tacere gains Pfizer deal; InterMune reports positive hep C results; ArQule CEO resigns; and much more...
January 8, 2008
SPOTLIGHT: Bisaro handed reigns at Watson
August 2, 2007
SPOTLIGHT: Abraxis buys facility
August 1, 2007
ALSO NOTED: Advanced Magnetics touts Phase III data; MicroIslet makes staffing changes; and much more...
July 23, 2007
ALSO NOTED: Emisphere fires CEO; Crucell in new antibody pact; Watson touts Phase III results; and much more...
January 15, 2007
ALSO NOTED: India funds training centers; Memory gains milestone;and much more...
October 31, 2006
SPOTLIGHT: Watson extends merger deadline
July 9, 2006
ALSO NOTED: BioMarin gets Orapred approval; FDA rejects Organon app; and much more...
June 1, 2006
ALSO NOTED: Biogen Idec, Elan start new Tysabri study; Watson to divest manufacturing facility in AZ; and much more...
March 29, 2006
DEALS: Watson buys Andrx for $1.9 billion
March 15, 2006
Watson to pay $1.9B for Andrx
March 12, 2006
FDA approves skin patch for depression
February 27, 2006
ALSO NOTED: Zactima hits fast track; BioCryst inks licensing pact; and much more...
February 1, 2006
SPOTLIGHT: Watson consolidating production operations
October 10, 2005

Paid Research Reports